Somatuline Autogel 90mg & 120mg (Lanreotide acetate)

Brief description of the problem (reason for recall)

The recall has been initiated due to a quality defect that may cause the needle to detach from the syringe body.

Advice for health professionals and distributors

You are requested to take the following action with regards to the affected batches:

• Return the affected product to your supplying distributor/wholesaler for a credit.
• If any of the recalled stock could have been transferred from your hospital/healthcare facility to another, please inform them of this recall alternatively inform Acino and provide us with their details.

Proposed action taken and its urgency: A SAHPRA approved recall letter was distributed to all distribution points and the recall process was initiated

Reporting side effects

Public and healthcare professionals are encouraged to report any side effects after using a health product or after immunisation by using the Med Safety App. Your report will contribute to our monitoring of these health products.